Changes in plasma insulin, enterostatin, and lipoprotein levels during an energy-restricted dietary regimen including a new oat-based liquid food

Annals of Nutrition and Metabolism

Volumn 40, Issue 4, 1996, Pages 212-220

  Rytter, E ^a   Erlanson Albertsson, C ^b   Lindahl, L ^c   Lundquist, I ^d   Viberg, U ^a   Akesson, B ^a   Oste R ^a  

^a Departments of Applied Nutrition and Food Chemistry   (Sweden)

^b Center for Molecular Biology   (Sweden)

^c Food Technology   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Energy restricted dietary regimen; Enterostatin; Insulin; Oat based liquid food; Plasma lipid levels; Weight loss

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; DIETARY FIBER; ENERGY CONSERVATION; FAT INTAKE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; OAT; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0029792199     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000177921     Document Type: Article

References (26)

1. Drcon DM., Frey-Hewitt B., Ellsworth N., Williams PT, Terry RB., Wood PD: Dietary fat carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988:47:995- 1000.
2. Tremblay A., Plourc G, Déspres JP., Bouchard C: Impact of dietary fat content and fat oxidation on energy intake in humans. Am.J. Clin Nutr 1989:47:799-805.
3. Thomas CT. Peters JC. Reed GW. Abumrad NN, Sun M, Hill JO: Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans. Am J Clin Nutr 1992:55: 934-942.
4. Bucmann B: A defective lipid oxidation as a main factor in the development of obesity? Scand J Nutr 1993: 37:2-5.
5. Platt JP: Fat, carbohydrates and weight. Ann NY Acad Sci 1993:683: 122-140.
6. Tempel DL, Leibowitz KJ, Leibo-witz SF: Effect of P.V.N. galanin on macronutricnt selection. Peptides 1986;7:1189-1192.
7. Bray GA: Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am J Clin Nutr 1992;55(suppl):265-271.
8. Erlanson-Albertsson C: Entcrosta-tin: The pancreatic procolipasc activation peptide - a signal for the regulation of fat intake. Nutr Rev 1992: 50:307-310.
9. Sumotf B, Strain GW: A perspective on the hormonal abnormalities of obesity: Are they cause or effect? ObcsRes 1994:2:56-67.
10. Barnes HA. Hutton JF. Walters K: An introduction to Rheology of Suspensions. Amsterdam, Elsevier. 1989. pp 115-139.
11. Becker W: Bcfolkningcns kostvanor och näringsintag. (Food habits and nutrient intake in Sweden). Vär Föda 1992:44:349-362.
12. Heding LG: A simplified insulin radioimmunoassay method; in Donato L. Milhaud G. Sirchis J (eds): Labelled Proteins in Tracer Studies. Brussels. Euratom. 1966. pp 345-350.
13. Bowyer RC. Jchanli AMT. Patel G. Hermon-Taylor J: Development of enzyme-linked immunosorbent assay for free human procolipase activation peptide (APGPR). Clin Chim Acta 1991;200:137-152.
14. Friedewald WT. Levy RI., Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultraccntrifugc. Clin Chcm 1972:18:499-502.
15. Garrow JS: Obesity; in Garrow JS. James WPT(eds): Human Nutrition and Dietetics, ed 9. Edinburgh. Churchill Livingstone, 1993. pp 465-479.
16. Woolcy SC, Garner DM: Dietary treatments for obesity are ineffective. BMJ 1994:309:655-656.
17. Astrup A, Raben A: Obesity: An inherited metabolic deficiency in the control of macronutricnt balance? Eur J Clin Nutr 1992:46:611-620.
18. Rolls BJ., Kim-Harris S, Fischman MW, Foitin RW., Moran TH., Stoner SA: Satiety after preloads with different amounts of fat and carbohydrate: Implications for obesity. Am J Clin Nutr 1994:60:476-487.
19. Shah M. McGovern P, French S, Baxter J: Comparison of a low-fat, ad libitum complex-carbohydrate diet with a low-energy diet in moderately obese women. Am J Clin Nutr 1994:59:980-984.
20. Mcnsink RP. Katan MB: Effect of different fatty acids on scrum lipids and lipoproteins. Artcrioscler Thronib 1992:12:911-919.
21. Ripsin CM. Keenan JM. Jacobs DR. Elmer PJ, Welch RR. Van Horn L, Liu K. Turnbull WH. Thye FW. Kestin M. Hegsted M. Davidson DM. Davidson MH. Dugan LD, Dc-mark-Wahnefriend W, Bcling S: Oat products and lipid lowering. JAMA 1992:267:3317-3325.
22. Okada S., York DA., Bray GA, Erlanson-Albertsson C: Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase selectively reduces fat intake. Physiol Behav 1991:49:1185-1189.
23. Miner JL. Erlanson-Albertsson C. Paterson JA. Bade CA: Reduction of feed intake in sheep by enterostatin. the procolipasc activation peptide. J AnimSci 1994:72:1578-1582.
24. Wcatherfood SC., Lattcrmann DF., Sipols AJ., Chavez M., Kermani ZR., York FS, Bray GA., Porte D Jr., Woods SC: Intraventricular administration of enterostatin decreases food intake in baboons. Appetite 1992:19:225.
25. Moi J. Bowyer RC. Jchanli AMT. Patel G. Erlanson-Albertsson C: Identification of enterostatin. the pancreatic procolipasc activation peptide, in the intestine of rat: Effect of CCK-8 and high-fat feeding. Pancreas 1993:8:488-493.
26. Duan RD. Wicker C. Erlanson-Albertsson C: Effect of insulin administration on contents, secretion and synthesis of pancreatic lipase and eolipasc in rats. Pancreas 1991:6: 595-602.